EWM
ACET icon

Edge Wealth Management’s Adicet Bio ACET Stock Holding History

Edge Wealth Management’s Portfolio ACET Stock Details ACET Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q4 		– Sell
-822
Closed -$156K – 386
2020
Q3 		$156K Buy
822
+348
+73% +$88K 0.04% 121
2020
Q2 		$114K Buy
+474
New +$93.1K 0.02% 185

Other funds holding ACET

O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
JJIJ
Johnson & Johnson Innovation - JJDC New Brunswick, New Jersey $978M AUM 102.17% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
NCM
Nantahala Capital Management New Canaan, Connecticut $2.72B AUM 121.58% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return
IC
Ikarian Capital Dallas, Texas $1.23B AUM 600.17% 1-Year Est. Return
AG
Artal Group Luxembourg $1.01B AUM 29.84% 1-Year Est. Return
JGC
J. Goldman & Co New York $3.44B AUM 33.82% 1-Year Est. Return
DCM
DAFNA Capital Management Los Angeles, California $440M AUM 109.12% 1-Year Est. Return

Edge Wealth Management's ACET Position: Q4 2020 in Review

Edge Wealth Management sold out of Adicet Bio (ACET) in Q4 2020, closing a stake of 822 shares — an estimated $156K sold.

Edge Wealth Management first reported a position in ACET in Q2 2020 and held it in 2 quarters. The position peaked at $156K in Q3 2020. 44 funds tracked by Wall St. Rank hold ACET as of Q4 2020.

  • Edge Wealth Management reported no remaining Adicet Bio position as of Q4 2020 after selling out during the quarter.
  • Edge Wealth Management sold 822 Adicet Bio shares in Q4 2020, an estimated $156K.
  • Edge Wealth Management first reported a position in Adicet Bio in Q2 2020 and held it in 2 quarters.
  • Edge Wealth Management's Adicet Bio position peaked at $156K in Q3 2020.
  • 44 funds tracked by Wall St. Rank held Adicet Bio as of Q4 2020.

Based on Edge Wealth Management's 13F filing for Q4 2020, filed 19 Jan 2021.